Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Variable phosphorylation states of pigment-epithelium-derived factor differentially regulate its function.

Galia Maik-Rachline1, Rony Seger

  • 1Department of Biological Regulation, The Weizmann Institute of Science, Rehovot 76100, Israel.

Blood
|December 3, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inhibition of Tumor Microenvironment-Driven JAK-STAT Signaling Enhances Response to Arginine Deprivation Therapy in Triple-Negative Breast Cancer.

Cells·2026
Same author

Re-epithelialization of cancer cells increases autophagy and DNA damage: Implications for breast cancer dormancy and relapse.

Science signaling·2025
Same author

Special Issue: MAPK Signaling Cascades in Human Health and Diseases.

International journal of molecular sciences·2024
Same author

Author Correction: ASS1 metabolically contributes to the nuclear and cytosolic p53-mediated DNA damage response.

Nature metabolism·2024
Same author

ASS1 metabolically contributes to the nuclear and cytosolic p53-mediated DNA damage response.

Nature metabolism·2024
Same author

Myotubularin-related-protein-7 inhibits mutant (G12V) K-RAS by direct interaction.

Cancer letters·2024

Pigment epithelium-derived factor (PEDF) activity depends on its phosphorylation state. Dual phosphorylation by PKA and CK2 enhances both neurotrophic and antiangiogenic effects, suggesting therapeutic potential.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Background:

  • Pigment epithelium-derived factor (PEDF) is a secreted protein with diverse biological roles.
  • PEDF exhibits both neurotrophic and antiangiogenic properties.
  • Previous studies indicated that PEDF's functions are modulated by phosphorylation.

Purpose of the Study:

  • To investigate the interplay between PKA and CK2 phosphorylation of PEDF.
  • To determine how differential phosphorylation affects PEDF's biological activities.
  • To explore the therapeutic potential of PEDF phosphorylation mutants.

Main Methods:

  • Site-directed mutagenesis to create PEDF phosphorylation mimics.
  • Analysis of PKA and CK2 phosphorylation patterns on wild-type and mutant PEDF.

Related Experiment Videos

  • Assessment of neurotrophic and antiangiogenic activities of PEDF variants.

    • Main Results:

    • A PEDF mutant mimicking CK2 phosphorylation was resistant to PKA phosphorylation.
    • A PEDF mutant mimicking PKA phosphorylation was a substrate for CK2.
    • Combined PKA and CK2 phosphorylation (triple phosphomimetic mutant) resulted in the strongest antiangiogenic and neurotrophic activities.
    • Individual phosphorylation site mutants showed reduced or single activities.

    Conclusions:

    • Differential phosphorylation of PEDF by PKA and CK2 dictates its distinct cellular activities.
    • The complex phosphorylation patterns contribute to the multifaceted actions of PEDF.
    • The triple phosphomimetic PEDF mutant holds promise for developing novel antiangiogenic and neurotrophic therapies.